Bank Julius Baer & Co
MYOV

Bank Julius Baer & Co’s Myovant Sciences Ltd. MYOV Stock Holding History

Bank Julius Baer & Co’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,080
Closed -$17K – 854
2021
Q4 		$17K Hold
1,080
– – ﹤0.01% 758
2021
Q3 		$24K Sell
1,080
-18
-2% -$395 ﹤0.01% 737
2021
Q2 		$25K Buy
1,098
+135
+14% +$2.84K ﹤0.01% 745
2021
Q1 		$20K Sell
963
-123
-11% -$2.8K ﹤0.01% 750
2020
Q4 		$30K Buy
+1,086
New +$21.1K ﹤0.01% 729

Other funds holding MYOV

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Bank Julius Baer & Co's MYOV Position: Q1 2022 in Review

Bank Julius Baer & Co sold out of Myovant Sciences Ltd. (MYOV) in Q1 2022, closing a stake of 1,080 shares — an estimated $17K sold.

Bank Julius Baer & Co first reported a position in MYOV in Q4 2020 and held it in 5 quarters. The position peaked at $30K in Q4 2020. 89 funds tracked by Wall St. Rank hold MYOV as of Q1 2022.

  • Bank Julius Baer & Co reported no remaining Myovant Sciences Ltd. position as of Q1 2022 after selling out during the quarter.
  • Bank Julius Baer & Co sold 1,080 Myovant Sciences Ltd. shares in Q1 2022, an estimated $17K.
  • Bank Julius Baer & Co first reported a position in Myovant Sciences Ltd. in Q4 2020 and held it in 5 quarters.
  • Bank Julius Baer & Co's Myovant Sciences Ltd. position peaked at $30K in Q4 2020.
  • 89 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2022.

Based on Bank Julius Baer & Co's 13F filing for Q1 2022, filed 9 May 2022.